BAP1 genetic testing among melanoma and cancer-prone families in Sweden

Authors

  • Hildur Helgadottir a Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; b Theme Cancer, Karolinska University Hospital, Stockholm, Sweden
  • Karina Schultz a Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; b Theme Cancer, Karolinska University Hospital, Stockholm, Sweden
  • Jan Lapins c Department of Dermatology, Karolinska University Hospital, Stockholm, Sweden; d Dermatology and Venereology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
  • Ismini Vassilaki e Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
  • Charlotta All-Eriksson f Department of Ophthalmology, Sahlgrenska University Hospital, Gothenburg, Sweden
  • Veronica Höiom a Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; b Theme Cancer, Karolinska University Hospital, Stockholm, Sweden

DOI:

https://doi.org/10.1080/0284186X.2023.2216338

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2023-06-03

How to Cite

Helgadottir, H., Schultz, K., Lapins, J., Vassilaki, I., All-Eriksson, C., & Höiom, V. (2023). BAP1 genetic testing among melanoma and cancer-prone families in Sweden. Acta Oncologica, 62(6), 565–570. https://doi.org/10.1080/0284186X.2023.2216338

Issue

Vol. 62 No. 6 (2023): Acta Oncologica

Section

Articles